As acknowledged in the limitation section and noted by the reviewer, the rarity of these tumors and the small number of patients in most series, including ours, limits analysis. Hence, we did not aim to generalize our outcome. Our focus was on how the use of these modern tools can facilitate maximum safe tumor removal which is considered a pivotal factor in the management of chordoma and chondrosarcoma.
It is therefore difficult to state that the results were clearly improved or to even compare to other series, without larger numbers and direct comparison or classification of individual tumor locations and characteristics in differing series.